Overview of Ursolic Acid Potential for the Treatment of Metabolic Disorders, Autoimmune Diseases, and Cancers via Nuclear Receptor Pathways

Abstract

Nuclear receptors (NRs) form a family of druggable transcription factors that are regulated by ligand binding to orchestrate multifaceted physiological functions, including reproduction, immunity, metabolism, and growth. NRs represent attractive and valid targets for the management and treatment of a vast array of ailments. Pentacyclic triterpenes (PTs) are ubiquitously distributed natural products in medicinal and aromatic plants, of which ursolic acid (UA) is an extensively studied member, due to its diverse bio-pertinent activities against different cancers, inflammation, aging, obesity, diabetes, dyslipidemia, and liver injury. In fact, PTs share a common lipophilic structure that resembles NRs’ endogenous ligands. Herein, we present a review of the literature on UA’s effect on NRs, showcasing the resulting health benefits and potential therapeutic outcomes. De facto, UA exhibited numerous pharmacodynamic effects on PPAR, LXR, FXR, and PXR, resulting in remarkable anti-inflammatory, anti-hyperlipidemic, and hepatoprotective properties, by lowering lipid accumulation in hepatocytes and mitigating non-alcoholic steatohepatitis (NASH) and its subsequent liver fibrosis. Furthermore, UA reversed valproate and rifampicin-induced hepatic lipid accumulation. Additionally, UA showed great promise for the treatment of autoimmune inflammatory diseases such as multiple sclerosis and autoimmune arthritis by antagonizing RORγ. UA exhibited antiproliferative effects against skin, prostate, and breast cancers, partially via PPARα and RORγ pathways. Herein, for the first time, we explore and provide insights into UA bioactivity with respect to NR modulation.

Beyond Psychotropic: Potential Repurposing of Fluoxetine toward Cancer Therapy

“…Raloxifene (RAL) is widely used for the treatment of estrogen receptor-positive breast cancer, with fewer side effects than the parent tamoxifen [ 66 , 67 ]. Kabel et al investigated the potential synergistic effect in the case of using a FLX/RAL combination in experimentally 7,12-Dimethyl Benzanthracene (DMBA)-induced breast cancer in female Wistar rats.…”

Pancreatic Cancer Management by Pentacyclic Triterpenes

“…Pentacyclic triterpenes (PTs) are hydrophobic phytochemicals existing in plants and endowed with a vast array of biological activities including, anti-inflammatory [43,44], anti-atherosclerotic [45,46], antihypertensive [45,47], hepatoprotective [48][49][50], anti-viral [51,52], anti-fibrosis [53,54], and anti-ulcer effects [55]. PTs and their semisynthetic derivatives are particularly promising anticancer agents with a favorable safety profile [56][57][58][59].…”

Discovery of Cytotoxic Truncated Vitamin D Derivatives Against Both Bortezomib‐Sensitive and Resistant Multiple Myeloma Phenotypes

“…There are two major isoforms of VD, vitamin D2 (VD2, ergocalciferol), and vitamin D3 (VD3, cholecalciferol) [18]. The basic role of VD is to maintain bone homeostasis via binding to its cognate nuclear receptor, vitamin D receptor (VDR, NR1I1) [19,20]. Interestingly, VD possesses other extra-skeletal bioactivities such as prevention and treatment of several types of cancers, nevertheless, the risk of hypercalcemia strongly hindered its clinical application in this regard [21][22][23][24].…”